ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
AN2 Therapeutics Inc

AN2 Therapeutics Inc (ANTX)

2.91
0.12
(4.30%)
Closed July 22 3:00PM
2.91
0.00
( 0.00% )
Pre Market: 6:34AM

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -10.33M-11.77M-12.48M-16.04M-16.6M-18.18M-18.82M-18.3M
Pre Tax Income -10.12M-11.34M-11.84M-15.32M-15.8M-16.71M-16.9M-16.62M
Net Income -10.12M-11.34M-11.84M-15.32M-15.8M-16.71M-16.9M-16.62M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -10.35M-11.81M-12.47M-15.32M-15.8M-16.71M-16.9M-16.62M
EBITDA -10.33M-11.77M-12.48M-16.04M-16.6M-18.18M-18.82M-18.3M
Year End December 30 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Revenue 000
Operating Income -21.61M-42.26M-69.64M
Pre Tax Income -21.54M-40.96M-64.73M
Net Income -28.06M-42.78M-64.73M
Preferred Dividends -6.52M-1.82M0
Basic Earnings Per Share (EPS) -0.005-2.205-2.177
EBIT -21.61M-42.31M-64.73M
EBITDA -21.61M-42.26M-69.64M

Your Recent History

Delayed Upgrade Clock